Introduction
C19H21N3O is a molecular formula that denotes a compound containing nineteen carbon atoms, twenty-one hydrogen atoms, three nitrogen atoms, and one oxygen atom. The arrangement of these atoms gives rise to a variety of structural possibilities, ranging from aromatic heterocycles to aliphatic chains. Compounds that satisfy this formula are encountered in organic chemistry, medicinal chemistry, and materials science, where the presence of nitrogen heteroatoms and a single oxygen atom can confer specific electronic, steric, and functional properties.
The formula can represent both natural products isolated from plant or microbial sources and synthetic molecules designed for pharmacological or industrial purposes. In the context of drug discovery, molecules with this composition are frequently evaluated for central nervous system activity, enzyme inhibition, or receptor modulation, owing to the ability of nitrogen atoms to participate in hydrogen bonding and charge delocalization.
Structural Aspects
General Formula and Composition
The stoichiometric representation C19H21N3O indicates a relatively large organic scaffold. The single oxygen atom is typically incorporated as a carbonyl group, hydroxyl group, ether, or amide linkage, while the three nitrogen atoms may reside in amine, amide, imine, or heterocyclic environments. The degree of unsaturation can be calculated using the double bond equivalent (DBE) formula: DBE = C – H/2 + N/2 + 1. Substituting the values yields DBE = 19 – 21/2 + 3/2 + 1 = 19 – 10.5 + 1.5 + 1 = 11. Thus, the compound possesses eleven degrees of unsaturation, indicating a combination of rings and double bonds typical of polyaromatic or heterocyclic frameworks.
Possible Structural Isomers
Given the high DBE value, several distinct classes of isomers can satisfy the formula:
- Aromatic heterocycles: Structures containing fused benzene rings with embedded nitrogen atoms, such as triazolobenzodiazepines, quinazoline derivatives, or imidazo[1,2-a]pyridines.
- Aliphatic amines: Compounds featuring secondary or tertiary amine side chains attached to a phenyl or heteroaryl core.
- Amide linkages: Molecules where the oxygen is part of a carbonyl group bound to nitrogen, forming urea, carbamate, or amide functionalities.
- Oxime or nitrile oxides: Structures where the oxygen participates in a N–O bond, providing potential sites for nucleophilic attack or oxidation.
Each isomer class brings distinct physicochemical properties. Aromatic systems typically exhibit high planarity, extended π-conjugation, and substantial lipophilicity, whereas aliphatic amines display higher basicity and solubility in aqueous media.
Physical and Chemical Properties
Melting Point and Boiling Point
For compounds with the C19H21N3O formula, reported melting points vary widely, depending on the degree of crystallinity and hydrogen-bonding capability. Aromatic amides generally melt between 120 °C and 250 °C, whereas tertiary amines may have lower melting points in the range of 50 °C to 150 °C. Boiling points are typically elevated (above 300 °C) for fused heterocycles, while more flexible molecules may evaporate at lower temperatures under reduced pressure.
Solubility
The solubility profile is dominated by the balance between aromatic hydrophobic domains and polar functional groups. Molecules with tertiary amine groups display enhanced water solubility due to protonation at physiological pH, whereas neutral heterocycles tend to be soluble in organic solvents such as chloroform, dichloromethane, or ethanol. The presence of a single oxygen atom, often in a carbonyl, contributes to dipole moments that can increase affinity for polar aprotic solvents.
Spectroscopic Signatures
In nuclear magnetic resonance (NMR) spectroscopy, aromatic protons appear in the 6.5–8.5 ppm region, whereas aliphatic methylene or methyl groups resonate between 0.5–3.5 ppm. The nitrogen atoms may not be directly observable in proton NMR but can influence chemical shifts of neighboring protons. In ^13C NMR, carbonyl carbons typically resonate near 160–180 ppm, while aromatic carbons appear between 110–140 ppm. Infrared (IR) spectra of these compounds usually show a strong absorption around 1650–1700 cm⁻¹ for C=O stretching, and N–H bending bands between 3200–3500 cm⁻¹ if secondary amine groups are present.
Synthesis and Production
General Synthetic Routes
The construction of C19H21N3O frameworks often proceeds through multi-step sequences involving heterocycle formation, amide coupling, and alkylation. Key strategies include:
- Condensation of aminobenzaldehydes with heterocyclic nucleophiles to generate imine intermediates that undergo cyclization.
- Amide bond formation via activation of carboxylic acids using coupling reagents such as HATU, EDCI, or DCC, followed by reaction with amines.
- Reductive amination of ketones or aldehydes with amines in the presence of reducing agents (NaBH₃CN, NaBH₄) to install tertiary amine centers.
- C–H activation methods employing transition-metal catalysis (palladium, copper) to append substituents onto aromatic rings.
Purification typically involves column chromatography, recrystallization, or preparative HPLC, depending on the desired purity and scale.
Industrial Production
Large-scale synthesis of compounds matching the C19H21N3O formula is usually tailored to a specific target molecule, such as a drug candidate or polymer monomer. Process optimization focuses on maximizing yield, minimizing side products, and ensuring compliance with Good Manufacturing Practice (GMP) standards. Key considerations include solvent selection for cost-effectiveness and environmental impact, as well as catalyst recycling when transition-metal catalysis is employed.
Applications
Pharmaceutical Use
Many compounds with this molecular composition are investigated or utilized as therapeutic agents. The presence of nitrogen heterocycles is common in drugs that interact with neurotransmitter receptors, such as serotonin or dopamine pathways. Examples include:
- Selective serotonin reuptake inhibitors (SSRIs) featuring triazole or imidazole rings.
- Antipsychotic agents that contain quinazoline cores.
- Anticancer drugs where a carbonyl group is part of a urea or amide linkage providing affinity for kinase active sites.
In each case, the tertiary amine or secondary amine groups enhance membrane permeability and influence pharmacokinetics.
Chemical Probes
Fluorescent or radiolabeled analogs of C19H21N3O molecules are employed as probes in biochemical assays. Their ability to bind selectively to protein targets enables studies of enzyme mechanisms, receptor occupancy, and signal transduction pathways. Modifications such as N-alkylation or N-acylation can alter the probe’s physicochemical properties, allowing for tailored affinity and specificity.
Materials Science
In polymer chemistry, monomers derived from C19H21N3O structures serve as building blocks for copolymers with enhanced thermal stability or electronic properties. For instance, heterocyclic monomers containing nitrogen can participate in charge-transfer complexes, improving conductivity when incorporated into conjugated polymers. Additionally, these monomers can act as crosslinking agents in the synthesis of thermosetting resins, contributing to improved mechanical strength.
Biological Activity
Receptor Binding
The nitrogen atoms within aromatic heterocycles frequently act as hydrogen bond acceptors or donors when interacting with amino acid residues in protein binding pockets. Studies employing radioligand displacement assays demonstrate that several C19H21N3O compounds exhibit high affinity for serotonin 5-HT₂A receptors, with Ki values in the low nanomolar range. Binding to dopamine D₂ receptors is also reported, particularly for triazolobenzodiazepine derivatives.
Enzyme Inhibition
Enzymes such as monoamine oxidase (MAO) and cytochrome P450 isoforms display susceptibility to inhibition by compounds containing nitrogen heterocycles. In vitro assays reveal that certain C19H21N3O analogs act as reversible inhibitors of MAO-A, providing a mechanistic basis for antidepressant activity. Additionally, these molecules can inhibit P450 2D6 by occupying the heme pocket, thereby affecting drug metabolism.
Pharmacokinetics
Absorption, distribution, metabolism, and excretion (ADME) profiles of C19H21N3O compounds depend largely on lipophilicity and basicity. The tertiary amine group tends to protonate at physiological pH, increasing aqueous solubility and potentially enhancing oral bioavailability. Metabolic pathways involve N-dealkylation, oxidation of aromatic rings, and conjugation with glucuronic acid or sulfate. In vivo studies in rodent models have shown half-lives ranging from 2 to 6 hours, with hepatic clearance as the primary elimination route.
Safety and Toxicology
Acute Toxicity
Acute toxicity studies conducted in laboratory animals indicate that many C19H21N3O compounds possess LD₅₀ values above 200 mg kg⁻¹ when administered orally, classifying them as low-to-moderate acute toxicity substances. Inhalation exposure risks are generally limited due to low vapor pressures of most aromatic analogs. Dermal absorption is minimal for non-ionized molecules, but formulations containing surfactants may increase skin permeability.
Chronic Exposure
Repeated-dose toxicity studies reveal potential effects on the central nervous system, including alterations in locomotor activity and neurochemical parameters. Some analogs have been associated with hepatotoxicity, manifesting as elevated serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels. Reproductive toxicity has not been observed in species where dosage levels exceeded therapeutic ranges, although comprehensive fertility studies are warranted for specific derivatives.
Carcinogenicity
Long-term carcinogenicity assessments, such as those performed in rodents over 18–24 months, have not demonstrated significant tumor induction for most C19H21N3O derivatives. However, specific structural motifs - particularly those containing electrophilic aryl nitro groups - may pose genotoxic risks. In vitro assays like the Ames test and micronucleus assay help screen for mutagenic potential early in development.
Regulatory Status
Regulatory classification of compounds with the C19H21N3O formula varies according to intended use. For pharmaceuticals, the United States Food and Drug Administration (FDA) and European Medicines Agency (EMA) evaluate safety and efficacy through a rigorous approval process that includes Phase I–III clinical trials. The classification often falls under Category A or B for CNS-active drugs, depending on the presence of functional groups that influence blood–brain barrier permeability.
In the context of chemical manufacturing, the European Union’s Registration, Evaluation, Authorization, and Restriction of Chemicals (REACH) directive requires detailed data on toxicological properties, environmental fate, and exposure levels. For industrial applications, Environmental Protection Agency (EPA) regulations pertaining to hazardous substances guide handling, storage, and disposal practices.
Research and Development
Lead Optimization
Medicinal chemists employ structure–activity relationship (SAR) studies to refine C19H21N3O scaffolds. Computational docking and quantitative free-energy perturbation calculations predict the impact of substituent modifications on target binding. Key optimization goals include improving selectivity for 5-HT₂A versus 5-HT₂C receptors and reducing off-target activity at α-adrenergic receptors.
Biological Imaging
Imaging research focuses on developing PET tracers based on C19H21N3O cores labeled with fluorine-18 (^18F) or carbon-11 (^11C). Preclinical imaging studies in non-human primates assess brain distribution and receptor occupancy. The ability to visualize receptor density changes in response to therapeutic intervention provides a valuable tool for both diagnostic and therapeutic monitoring.
Materials Applications
Efforts to create organic light-emitting diodes (OLEDs) incorporate C19H21N3O heterocyclic units as emissive layers. Photophysical studies indicate that these units contribute to high photoluminescence quantum yields (>80 %) when incorporated into thin films. Research into polymer blends that combine nitrogen heterocycles with phosphorescent dopants aims to achieve efficient triplet harvesting, potentially lowering the energy consumption of display technologies.
Conclusion
Compounds characterized by the C19H21N3O molecular formula represent a versatile class of organic molecules with significant relevance across pharmaceuticals, chemical biology, and materials science. Their diverse physicochemical traits, coupled with the capacity to interact selectively with biological targets, underpin ongoing advances in therapeutic development and analytical technology. Continued research into their synthesis, pharmacology, and safety profiles will enhance the potential for novel applications while ensuring responsible stewardship in industrial contexts.
No comments yet. Be the first to comment!